HBM Healthcare Investments (Cayman) Ltd.

CIK 1232258 · View on SEC EDGAR ↗

Insider

First SEC filing: Feb. 9, 2023 · Latest: Feb. 9, 2023

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 14 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

14 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Feb. 14, 2023 MLYS P 312,500 $16.00 $5,000,000 3,218,106 Direct +10.76% Acquired 62.4% (price as of 2026-08-21)
Dec. 17, 2013 PTCT S 66,667 $19.08 $1,272,006 2,441,504 Direct -2.66% Disposed 270.1% (price as of 2026-08-21)
June 25, 2013 PTCT P 666,676 $15.00 $10,000,140 2,508,171 Direct +36.20% Acquired 370.7% (price as of 2026-08-21)
March 25, 2013 PCRX S 10b5-1 165,541 $28.28 $4,681,499 2,233,993 Direct -6.90% Disposed -15.2% (price as of 2026-08-21)
March 22, 2013 PCRX S 10b5-1 113,928 $27.52 $3,135,299 2,399,534 Direct -4.53% Disposed -12.8% (price as of 2026-08-21)
March 21, 2013 PCRX S 10b5-1 11,431 $27.50 $314,352 2,513,462 Direct -0.45% Disposed -12.8% (price as of 2026-08-21)
March 19, 2013 PCRX S 10b5-1 9,100 $27.86 $253,526 2,524,893 Direct -0.36% Disposed -13.9% (price as of 2026-08-21)
March 18, 2013 PCRX S 10b5-1 400,000 $28.19 $11,276,000 2,533,993 Direct -13.63% Disposed -14.9% (price as of 2026-08-21)
March 11, 2013 PCRX S 10b5-1 500,000 $27.86 $13,930,000 2,933,993 Direct -14.56% Disposed -13.9% (price as of 2026-08-21)
Nov. 21, 2011 PCRX P 307,692 $6.50 $1,999,998 3,445,289 Direct +9.81% Acquired 269.1% (price as of 2026-08-21)
Feb. 8, 2011 PCRX P 267,857 $7.00 $1,874,999 2,869,740 Direct +10.29% Acquired 242.7% (price as of 2026-08-21)
Feb. 8, 2011 PCRX P 267,857 $7.00 $1,874,999 3,137,597 Direct +9.33% Acquired 242.7% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Feb. 14, 2023 MLYS Series B Preferred Stock Common Stock (964,238) — — 10,411,846 Disposed
Feb. 14, 2023 MLYS Series A Preferred Stock Common Stock (1,941,368) — — 20,962,895 Disposed
May 4, 2021 HOWL Series B Preferred Stock Common Stock (625,995) — — 5,426,819 Acquired
June 25, 2013 PTCT Series Five Junior Preferred Stock Common Stock (1,561,317) $0.00 — 1,561,317 Disposed
June 25, 2013 PTCT Series Four Senior Preferred Stock Common Stock (280,178) $0.00 — 280,178 Disposed
Feb. 8, 2011 PCRX Series A Convertible Stock Common Stock (1,487,680) — — 1,487,680 Disposed
Feb. 8, 2011 PCRX Convertible Promissory Note Common Stock (1,021,223) $13.44 — 1,021,223 Disposed

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 10 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Feb. 9, 2023 MLYS Series A Preferred Stock→ Common Stock (1,941,368) 1,941,368 Direct
Feb. 9, 2023 MLYS Series B Preferred Stock→ Common Stock (964,238) 964,238 Direct
April 29, 2021 HOWL Series B Preferred Stock→ Common Stock (625,995) 625,995 Direct
June 25, 2013 PTCT Series Four Senior Preferred Stock→ Common Stock (280,178) 280,178 Direct
June 25, 2013 PTCT Series Five Junior Preferred Stock→ Common Stock (1,561,317) 1,561,317 Direct
Feb. 2, 2011 PCRX Common Stock 92,980 Direct
Feb. 2, 2011 PCRX Series A Convertible Stock→ Common Stock (1,487,680) 1,487,680 Direct
Feb. 2, 2011 PCRX Common Stock Warrant s(Right to Buy)→ Common Stock (37,192) 37,192 Direct
Feb. 2, 2011 PCRX Common Stock Warrants (Right to Buy)→ Common Stock (41,841) 41,841 Direct
Feb. 2, 2011 PCRX Convertible Promissory Notes→ Common Stock (1,021,223) 1,021,223 Direct